Skip to content

30 Mar 2015 - 11:59

ZIMBABWE requires about $22,5 million annually to monitor the health of 750,000 HIV positive locals who are currently on anti-retroviral treatment (ART). The latest World Health Organisation (WHO) HIV treatment guidelines call for patients to receive a viral load test once a year to allow the switching of clients to favourable drugs. A viral load test measures the number of HIV particles in a blood sample. However, due to limited funds, Zimbabwe is presently providing repeat CD4 count checks which are considerably cheaper than viral load testing. Ministry health Aids and TB Unit director, Owen Mugurungi, said the government does not have the money for viral load monitoring, forcing the country to rely on CD4 counts.

27 Mar 2015 - 10:28

News Medical
25 March 2015
Phase 3 STAND Trial Launches to Advance PaMZ through Final Stage of Testing

PRETORIA - A new tuberculosis (TB) drug regimen designed to improve options for TB therapy eliminated more bacteria from sputum than standard therapy and did so at a faster rate, according to data from a phase 2b clinical trial published today in The Lancet. These results are published just as the global phase 3 clinical trial, designed to bring this regimen through the last stage of testing, has begun.

PaMZ is a three-drug regimen comprised of two candidate drugs that are not yet licensed for use against TB: pretomanid (Pa), formerly known as PA-824, and moxifloxacin (M), and one antibiotic, pyrazinamide (Z), which is approved for use in TB treatment today. The therapy is intended for those patients whose TB infections are sensitive to the three drugs, including people with drug-sensitive and multidrug-resistant TB (MDR-TB).

25 Mar 2015 - 20:41

HEALTH activists have launched a campaign to lobby churches and other institutions to view HIV as a health and not moral issue so as to eradicate stigma associated with the condition.

By Phyllis Mbanje News Day

This was revealed during the launch of the Zimbabwe Stigma Index (ZSI) report convened by the Zimbabwe National Network of People Living with HIV (ZNNP+) in Harare.

The ZSI is a research initiative driven and implemented by people living with HIV. It seeks to measure the levels of stigma associated with HIV.

Participants called on church leaders to be open about HIV and Aids issues and discourage congregants from looking at it from a moralistic point of view which they described as judgmental.

glqxz9283 sfy39587stf01